AeroVironment (AVAV) Q1 2027 Earnings Call Transcript

AeroVironment reported fiscal Q1 2027 revenue of $480.5 million, up 6% year over year, non-GAAP EPS of $0.59, up 84%, and $683 million of bookings, producing a 1.4x book-to-bill ratio. Funded backlog reached a record $1.5 billion, up 37% year over year, while the company reaffirmed FY2027 revenue guidance of $2.125-$2.225 billion and adjusted EBITDA guidance of $305-$325 million. Growth in autonomous systems and counter-UAS programs, including a nearly $465 million LOCUST laser contract, was partly offset by a 21% revenue decline in Space, Cyber and Directed Energy following the SCAR contract termination. Capacity-expansion CapEx will keep FY2027 free cash flow negative, and management cited uncertainty around the timing of U.S. congressional budget approval.

Analysis

The key equity debate is shifting from demand to conversion: AVAV is spending ahead of production while its largest new franchises remain early in the manufacturing ramp. If directed-energy programs transition from development into repeatable fixed-price production, product mix can lift consolidated EBITDA materially over the next 12-24 months; if qualification, supplier yield, or customer acceptance slips, the same fixed-cost buildout amplifies downside. The company’s reported EBITDA figures also differ between prepared remarks and the summarized data, making the 10-Q reconciliation and segment-level margin bridge an immediate diligence item rather than accepting the headline beat.

Near-term earnings risk is unusually concentrated: roughly 70% of annual EPS is expected in the second half, while free cash flow remains negative as inventory and facilities are funded ahead of deliveries. That creates a 1-3 month setup where a delayed appropriations process, continuing resolution, or slower conversion of IDIQ/task-order capacity can pressure the stock despite intact long-term demand. Watch funded-backlog conversion, unbilled receivables, inventory turns, and second-quarter mix; a miss on any of these would challenge the premise that capacity investment is self-financing.

The non-obvious competitive effect is that AVAV’s counter-UAS portfolio can displace higher-cost interceptor consumption at RTX, LMT and NOC in low-cost-drone defense, but those primes remain likely system integrators and channel partners on layered-defense deployments. AVAV’s domestic supply-chain positioning could improve bid competitiveness if import restrictions tighten, particularly versus smaller drone competitors dependent on foreign electronics; however, localized international production requirements can dilute margins and consume management bandwidth before export revenue scales.

Consensus may be assigning too much value to theoretical multibillion-dollar directed-energy TAM before production evidence exists. The upside is real if repeat orders follow initial deployments, but the appropriate rerating trigger is sustained SCDE profitability and cash conversion—not additional IDIQ ceilings or customer demonstrations.

Key Decisions for Investors

• Maintain a tactical long AVAV only on pullbacks tied to budget-timing headlines, with a 6-12 month horizon into second-half delivery concentration. Size modestly until the 10-Q confirms EBITDA reconciliation, working-capital trajectory, and the gross-margin bridge; target 20-30% upside if second-half execution validates production mix, with a 12-15% risk limit on guidance or funded-backlog conversion deterioration.
• Prefer a defined-risk expression: buy AVAV 6-9 month call spreads after the next quarterly report rather than front-month calls. The catalyst is evidence that SCDE turns profitable and that product-margin expansion offsets elevated SG&A; exit if full-year EBITDA guidance is reduced or fiscal-year free-cash-flow expectations worsen beyond planned expansion spending.
• Use AVAV/KTOS as a relative-value watch pair rather than an immediate trade: long AVAV versus short KTOS only if AVAV demonstrates two consecutive quarters of directed-energy production conversion while KTOS fails to show comparable counter-UAS order conversion. The pair isolates the unmanned-defense theme but is vulnerable to broad defense-budget strength and differing program timing.
• Set an alert for a prolonged continuing resolution or a slip in final defense appropriations beyond the company’s assumed timing. In that event, reduce AVAV exposure before second-half estimates reset; the stock’s valuation will be most sensitive to delayed revenue recognition because capex, depreciation, and inventory commitments are already being incurred.